Internal Medicine, Hematology & Oncology · Sellersville, PA
NPI
1013954643
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
915 Lawn Ave, Suite 202
Sellersville, PA, 18960
Phone (215) 453-3300
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.1M
186,494 services
Medicare patients, 2024
713
Average age 76
Drug cost, 2024
$3.1M
1,352 prescriptions
Company payments, 2025
$921
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lorraine C Snyder Dougherty was code J1439 (injection, ferric carboxymaltose, 1 mg), 22,500 times for 16 patients. In total Lorraine C Snyder Dougherty billed 186,494 services in 119 codes, and Medicare paid $3.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 22,500 | 16 | $0.83 | $19K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 15,150 | 28 | $0.11 | $1,670 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 13,320 | 19 | $2.31 | $31K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 13,002 | 33 | $21.14 | $275K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 8,000 | 13 | $43.86 | $351K |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,878 | 12 | $0.08 | $453 |
| J0897 Injection, denosumab, 1 mg | Office | 5,040 | 22 | $20.36 | $103K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 4,900 | 39 | $15.68 | $77K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 4,340 | 13 | $36.98 | $161K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,714 | 63 | $0.09 | $243 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,420 | 40 | $0.72 | $1,025 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 740 | 13 | $0.25 | $186 |
| 96375 Injection Administration | Office | 686 | 96 | $13.08 | $8,973 |
| 99214 Office E&M - Established | Office | 481 | 217 | $104.87 | $50K |
| 96372 Injection Administration | Office | 455 | 101 | $11.94 | $5,432 |
By year: 2022 $2.6M for 202,354 services; 2023 $3.0M for 216,972 services; 2024 $3.1M for 186,494 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 195 | 83 | $8.65 | $1,687 |
| 85025 Blood Count | 158 | 55 | $7.57 | $1,196 |
Medicare prescription drug claims, 2024
In 2024, the drug Lorraine C Snyder Dougherty prescribed most often to Medicare patients was Letrozole, with 273 prescriptions and refills. In total Lorraine C Snyder Dougherty wrote 1,352 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 273 | 599 | 81 | $5,314 |
| Eliquis Apixaban | 107 | 143 | 32 | $83K |
| Hydroxyurea Generic | 73 | 148 | 21 | $1,574 |
| Dexamethasone Generic | 67 | 72 | 24 | $886 |
| Prednisone Generic | 53 | 56 | 16 | $458 |
| Prochlorperazine Maleate Generic | 44 | 44 | 35 | $566 |
| Gabapentin Generic | 39 | 45 | 19 | $237 |
| Anastrozole Generic | 37 | 107 | 14 | $1,539 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 36 | 36 | 30 | $367 |
| Acyclovir Generic | 36 | 53 | 13 | $713 |
| Warfarin Sodium Generic | 36 | 88 | Under 11 | $378 |
| Xarelto Rivaroxaban | 34 | 61 | Under 11 | $33K |
| Tamoxifen Citrate Generic | 33 | 73 | Under 11 | $844 |
| Ondansetron Odt Ondansetron | 32 | 32 | 27 | $276 |
| Ondansetron Hcl Generic | 27 | 27 | 13 | $206 |
Brand drugs: 320 claims; generic drugs: 1,032 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lorraine C Snyder Dougherty $921 ($921 in general payments such as food, travel and fees) from 20 companies. The largest payer was Genzyme Corporation with $101.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 2 | $101 |
| Abbvie Inc. ABBV | 4 | $97.74 |
| Pfizer Inc. PFE | 5 | $87.73 |
| Seagen Inc. PFE | 1 | $75.99 |
| GlaxoSmithKline, LLC. GSK | 3 | $59.65 |
| Merck Sharp & Dohme LLC MRK | 3 | $59.47 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $58.06 |
| Daiichi Sankyo Inc. 4568.T | 2 | $55.71 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $53.6 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $44.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.